Category: Papers

2019

  • Read Zaniolo O, Ghetti G, Povero M, Pradelli L. Effectiveness of Long-Acting Injectable Antipsychotics in Schizophrenia: A Literature Review and Bayesian Meta-Analysis Informing Economic Considerations. Farmeconomia. Health economics and therapeutic pathways 2019; 20(1): 13-24

2018

  • Read Povero M, Miceli A, Pradelli L, Ferrarini M, Pinciroli M, Glauber M. Cost-utility of surgical sutureless bioprostheses vs TAVI in aortic valve replacement for patients at intermediate and high surgical risk. Clinicoecon Outcomes Res 2018 Nov 8;10:733-745
  • Read Correia MITD, Perman MI, Pradelli L, Omaralsaleh AJ, Waitzberg DL. Economic burden of hospital malnutrition and the cost-benefit of supplemental parenteral nutrition in critically ill patients in Latin America. J Med Econ 2018 Nov;21(11):1047-1056
  • Read Schraag S, Pradelli L, Alsaleh AJO, Bellone M, Ghetti G, Chung TL, Westphal M, Rehberg S. Propofol vs. inhalational agents to maintain general anaesthesia in ambulatory and in-patient surgery: a systematic review and meta-analysis. BMC Anesthesiol 2018 Nov 8;18(1):162
  • Read Dal Negro RW, Turco P, Povero M. Cost of influenza and influenza-like syndromes (I-LSs) in Italy: Results of a cross-sectional telephone survey on a representative sample of general population. Respiratory Medicine, Volume 141, 144-149
  • Read Dal Negro RW, Zanasi A, Turco P, Povero M. Influenza and influenza-like syndromes: the subjects’ beliefs, the attitude to prevention and treatment, and the impact in Italian general population. Multidisciplinary Respiratory Medicine (2018) 13:7
  • Read Dal Negro RW, Turco P, Povero M. Cost of acute cough in Italian children. ClinicoEconomics and Outcomes Research 2018:10 529–537
  • Read Bellone M, Pradelli L, Bo M. Estimating the cost-effectiveness of treatment for prevention of thromboembolic events in at-risk adults with non-valvular atrial fibrillation. Farmeconomia. Health economics and therapeutic pathways 2018; 19(1): 11-20
  • Read Pradelli L, Villa S, Castaman G. Albutrepenonacog alfa (Idelvion®) for the treatment of Italian patients with hemophilia B: a budget impact model Farmeconomia. Health economics and therapeutic pathways 2018; 19(1): 1-10

2017

  • ReadPradelli L, Povero M, Bürkle H, Kampmeier TG, Della-Rocca G, Feuersenger A, Baron JF, Westphal M. Propofol or benzodiazepines for short- and long-term sedation in intensive care units? An economic evaluation based on meta-analytic results. Clinicoecon Outcomes Res. 2017 Nov 9;9:685-698
  • ReadFeng Y, Li C, Zhang T, Pradelli L. Parenteral nutrition including an omega-3 fatty-acid-containing lipid emulsion for intensive care patients in China: a pharmacoeconomic analysis. Clinicoecon Outcomes Res. 2017 Sep 5;9:547-555
  • ReadCalder PC, Adolph M, Deutz NE, Grau T, Innes JK, Klek S, Lev S, Mayer K, Michael-Titus AT, Pradelli L, Puder M, Vlaardingerbroek H, Singer P. Lipids in the intensive care unit: Recommendations from the ESPEN Expert Group. Clin Nutr. 2017 Sep 7. pii: S0261-5614(17)30315-1
  • ReadCastiglia P, Pradelli L, Castagna S, Freguglia V, Palù G, Esposito S. Overall effectiveness of pneumococcal conjugate vaccines: An economic analysis of PHiD-CV and PCV-13 in the immunization of infants in Italy. Hum Vaccin Immunother. 2017 Oct 3; 13(10): 2307-2315
  • ReadPradelli L, Di Perri G, Rizzardini G, Martelli E, Giardina S, Povero M. A cost-effectiveness analysis of E/C/F/TAF vs three boosted regimens in the Italian context. Farmeconomia. Health economics and therapeutic pathways 2017; 18(1): 113-127
  • ReadPradelli L, Ghetti G. A general model for the estimation of societal costs of lost production and informal care in Italy. Farmeconomia. Health economics and therapeutic pathways 2017; 18(1): 5-14
  • ReadDal Negro R, Turco P, Povero M. The Global Usability Score: A Novel Comprehensive Tool for Assessing, Ranking, and Compare Usability of Inhalers in Patients Requiring Airway Treatments. J Pulm Respir Med. 2017;7:401
  • ReadWu GH, Ehm A, Bellone M, Pradelli L. Pharmacoeconomics of parenteral nutrition in surgical and critically ill patients receiving structured triglycerides in China. Asia Pac J Clin Nutr. 2017; 26(6): 1021-1031
  • ReadPradelli L, Graf S, Pichard C, Berger MM. Supplemental parenteral nutrition in intensive care patients: A cost saving strategy. Clin Nutr. 2017 Jan 25. pii: S0261-5614(17)30033-X

2016

  • ReadBellone M, Di Virgilio R, Di Rienzo P. Budget impact analysis of apixaban to treat and prevent venous thromboembolism in Italy. Farmeconomia. Health economics and therapeutic pathways 2016; 17(3): 127-136
  • ReadPradelli L, Ascierto P. Valutazione clinica ed economica dell’introduzione sul mercato italiano della combinazione trametinib + dabrafenib nel trattamento del melanoma in stadio avanzato. Farmeconomia. Health economics and therapeutic pathways 2016; 17(Suppl 3): 1-32
  • ReadDal Negro W, Povero M. Cultural and linguistic validation of the NHQ-2 Questionnaire: a specific instrument for assessing patient’s usability of inhalation devices. Multidiscip Respir Med. 2016 Aug 23;11:32
  • ReadDal Negro W, Povero M. Dry-powder inhalers in patients with persistent airflow limitation: usability and preference. Multidiscip Respir Med. 2016 Sep 5;11:31
  • ReadDal Negro W, Povero M. Acceptability and preference of three inhalation devices assessed by the Handling Questionnaire in asthma and COPD patients. Multidiscip Respir Med. 2016 Feb 10;11:7
  • ReadAdami S, Maggi P, Montinaro V, Povero M, Pradelli L, Bellagamba R, Bonfanti P, Di Biagio A, Rusconi S, Di Campli FM, Forastieri G, Mancini M. Simulating the development and progression of Chronic Kidney Disease and osteoporosis in people living with HIV. Farmeconomia. Health economics and therapeutic pathways 2016;17(S1):3-23
  • ReadWu GH, Zaniolo O, Schuster H, Schlotzer E, Pradelli L. Structured triglycerides versus physical mixtures of medium- and long-chain triglycerides for parenteral nutrition in surgical or critically ill adult patients: Systematic review and meta-analysis. Clinical Nutrition, epub available online 21 January 2016

2015

  • ReadPovero M, Pradelli L. Comparison between traditional and goal directed perfusion in cardiopulmonary by-pass. Adaptation of a differential cost analysis Farmeconomia. Health economics and therapeutic pathways 2015;16(S1):3-16.
  • ReadPovero M, Pradelli L. Comparison between traditional and goal directed perfusion in cardiopulmonary by-pass. A differential cost analysis in US. Farmeconomia. Health economics and therapeutic pathways 2015;16(3):77-86.
  • ReadWu GH, Gao J, Ji CY, Pradelli L, Xi QL, Zhuang QL. Cost and effectiveness of omega-3 fatty acid supplementation in Chinese ICU patients receiving parenteral nutrition. Clinicoecon Outcomes Res. 2015 Jun 26;7:369-75.
  • ReadPradelli L, Povero M, Muscaritoli M, Eandi M. Updated cost-effectiveness analysis of supplemental glutamine for parenteral nutrition of intensive-care patients. Eur J Clin Nutr 2015 May;69(5):546-51
  • ReadEandi M, Gandini G, Povero M, Zaniolo O, Pradelli L, Aprili G. Plasma for fractionation in a public setting: cost analysis from the perspective of the third-party payer. Blood Transfus 2015 Jan;13(1):37-45

2014

  • ReadPradelli L, Calandriello M, Di Virgilio R, Bellone M, Tubaro M. Comparative pharmaco-economic assessment of apixaban versus standard of care for the prevention of stroke in Italian atrial fibrillation patients. Farmeconomia. Health economics and therapeutic pathways 2014; 15(Suppl 1): 15-25
  • ReadPradelli L, Calandriello M, Di Virgilio R, Bellone M, Tubaro M. Budget impact analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients. Farmeconomia. Health economics and therapeutic pathways 2014; 15(Suppl 1): 5-14
  • ReadPradelli L, Calandriello M, Di Virgilio R, Bellone M, Tubaro M. Cost effectiveness analysis of apixaban versus other NOACs  for the prevention of stroke in Italian atrial fibrillation patients. Farmeconomia. Health economics and therapeutic pathways 2014; 15(4): 101-112
  • ReadMancini N, Sambri V, Corti C, Ghidoli N, Tolomelli G, Paolucci M, Clerici D, Carletti S, Greco R, Tassara M, Pizzorno B, Zaniolo O, Povero M, Pradelli L, Burioni R, Stanzani M, Landini MP, Ciceri F, Clementi M. Cost-effectiveness of blood culture and a multiplex real-time PCR in hematological patients with suspected sepsis: an observational propensity score-matched study. Expert Rev Mol Diagn 2014; 14(5): 623-32
  • ReadPradelli L, Eandi M, Povero M, Mayer K, Muscaritoli M, Heller AR, Fries-Schaffner E. Cost-effectiveness of omega-3 fatty acid supplements in parenteral nutrition therapy in hospitals: a discrete event simulation model. Clin Nutr 2014; 33(5): 785-92
  • ReadPovero M, Pradelli L, Turco P, Dal Negro RW. Real-life cost and cost-effectiveness for tiotropium 18 μg od monotherapy in moderate and severe COPD patients: a 48-month survey. Farmeconomia. Health economics and therapeutic pathways 2014; 15(2): 39-44

2013

  • ReadPaggiaro P, Patel S, Nicolini G, Pradelli L, Zaniolo O, Papi A. Stepping down from high dose fluticasone/salmeterol to extrafine BDP/F in asthma is cost-effective. Respir Med 2013; 107(10): 1531-7
  • ReadBellone M, Sbarra P. A cost-minimization analysis of combination therapy in hypertension: fixed-dose vs extemporary combinations. Farmeconomia. Health economics and therapeutic pathways 2013; 14(4): 153-160
  • ReadZaniolo O, Povero M. ISPOR 2013: what’s new and what’s old? Farmeconomia. Health economics and therapeutic pathways 2013; 14(4): 151-152
  • ReadZaniolo O, Povero M, Bonfanti P, Borderi M, Medaglia M. First-line HIV treatment: evaluation of backbone choice and its budget impact. Farmeconomia. Health economics and therapeutic pathways 2013; 14(2): 75-87
  • ReadEandi M, Pradelli L, Povero M. Costs of treatment of haemophilia A in Italy: comparison of the use of plasma-derived and recombinant FVIII using a discrete event simulation (DES) model. Farmeconomia. Health economics and therapeutic pathways 2013; 14(2): 51-74

2012

  • ReadPradelli L, Mayer K, Muscaritoli M, Heller AR. n-3 fatty acid-enriched parenteral nutrition regimens in elective surgical and ICU patients: a meta-analysis. Crit Care 2012; 16(5): R184
  • ReadDal Negro RW, Tognella S, Pradelli L. A 36-month study on the cost/utility of add-on omalizumab in persistent difficult-to-treat atopic asthma in Italy. J Asthma 2012; 49(8): 843-8
  • ReadPradelli L, Zaniolo O. Perceval Sutureless valves in isolated and concomitant AVR procedures: an economic model shows overall decrease of costs for isolated or combined operations. Farmeconomia. Health economics and therapeutic pathways 2012; 13(4): 159-174
  • ReadPradelli L, Iannazzo S, Zaniolo O, Muscaritoli M, Eandi M. Effectiveness and Cost-Effectiveness of Supplemental Glutamine Dipeptide in Total Parenteral Nutrition Therapy for Critically Ill Patients: A Discrete Event Simulation Model Based on Italian data. International Journal of Technology Assessment in Health Care 2012; 28(1): 22–28
  • ReadIannazzo S, Carsi M, Chiroli S. A cost-utility analysis of cinacalcet in secondary hyperparathyroidism in five European countries. Appl Health Econ Health Policy 2012; 10(2): 127-38
  • ReadZaniolo O, Iannazzo S, Pradelli L, Miravitlles M. Pharmacoeconomic evaluation of tiotropium bromide in the long-term treatment of chronic obstructive pulmonary disease (COPD) in Italy. Eur J Health Econ 2012; 13(1): 71-80

2011

  • ReadSacchi V. Gefitinib: a pharmacoeconomic profile of its use in patients with Non Small Cell Lung Cancer EGFR+. Farmeconomia e percorsi terapeutici 2011; 12(2): 77-85
  • ReadZaniolo O, Iannazzo S, Patrucco GP, Bellini R. Cost-effectiveness evaluations of spinal neuromodulation with ziconotide continuous infusion in cancer pain in a real clinical practice. Farmeconomia e percorsi terapeutici 2011; 12(2): 87-94
  • ReadZaniolo O, Carsi M, Iannazzo S. Tiotropium bromide in the routine care of GOLD stage II COPD patients: a pharmaeconomic evaluation. Farmeconomia e percorsi terapeutici 2011; 12(2): 45-52
  • ReadZaniolo O, Bettoncelli G, Bosio G, Mantovani L, Pistelli R, Vaghi A, Villa M, Iannazzo S, Bamfi F, Frizzo V, Dal Negro RW. Estimation of economic consequences of GOLD guidelines adoption in the Italian clinical practice. Farmeconomia e percorsi terapeutici 2011; 12(1): 5-19
  • ReadDal Negro RW, Pradelli L, Tognella S, Micheletto C, Iannazzo S. Cost-utility of add-on omalizumab in difficult-to-treat allergic asthma in Italy. Eur Ann Allergy Clin Immunol 2011; 43(2): 45-53
  • ReadIannazzo S, Pradelli L, Carsi M, Perachino M. Cost-effectiveness analysis of LHRH agonists in the treatment of metastatic prostate cancer in Italy. Value Health 2011; 14(1): 80-9
  • ReadIannazzo S. Pharmacoeconomic evaluation of the MF59–adjuvanted influenza vaccine in the elderly population in Italy. J Prev Med Hyg 2011; 52(1):1-8

2010

  • ReadCapri S, Benucci M, Iannazzo S, Zaniolo O, D’Arpino A. Un modello di Budget Impact per la valutazione economica di tocilizumab come prima linea biologica nei pazienti con artrite reumatoide di grado moderato o severo. Italian Journal of Public Health – Year 8, Volume 7, Number 2, Suppl 2, 2010: S44-53
  • ReadEandi M, Pradelli L, Iannazzo S, Chiroli S, Pontoriero G. Economic evaluation of cinacalcet in the treatment of secondary hyperparathyroidism in Italy. Pharmacoeconomics 2010; 28(11): 1041-54
  • ReadBenucci M, Iannazzo S, Zaniolo O, Sabadini L. Rituximab in the treatment of rheumatoid arthritis patients in Italy: a budget impact analysis. Clin Exp Rheumatol 2010; 28(5): 722-7
  • ReadPradelli L, Iannazzo S, Zaniolo O, Botrugno P. Organization and Estimated Patient-Borne Costs of Oral Anticoagulation Therapy in Italy: Results from a Survey. Appl Health Econ Health Policy 2010; 8 (2): 119-128
  • ReadZaniolo O, Wolowacz SE, Pradelli L. Cost/effectiveness model of dabigatran in the prevention of venous thromboembolism in major orthopedic surgery: Adaptation for Italy. Farmeconomia e percorsi terapeutici 2010; 11(2): 91-101
  • ReadSacchi V, Zaniolo O, Olivieri I. Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept. Farmeconomia e percorsi terapeutici 2010; 11(2): 63-76
  • ReadZaniolo O, Sacchi V, Dal Negro RW. Tiotropium in COPD: clinical outcomes and economic evidence. Farmeconomia e percorsi terapeutici 2010; 11(1): 27-41